Home
Stock
ETF
Institutional Holdings
Compound interest
Blog
Support Me
Login
Join us
Français
English
NASDAQ
/
Healthcare
/
Medical - Diagnostics & Research
/
BLLN
BillionToOne, Inc.
BLLN
Summary
30-Y Financials
Dividend
Analyst
Peer analysis
Key metrics
Ownership / Senat
BLLN
BillionToOne, Inc.
Net profit
EBITDA
P/E Ratio
Capitalization
Performance
Periode
BLLN
6M
-11.73 %
YTD
-11.73 %
1Y
-11.73 %
3Y
-11.73 %
5Y
-11.73 %
10Y
-11.73 %
From the beginning
-11.73 %
Dividend